相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Increase in Glutamatergic Terminals in the Striatum Following Dopamine Depletion in a Rat Model of Parkinson's Disease
Xuefeng Zheng et al.
NEUROCHEMICAL RESEARCH (2019)
Iron-induced oxidative stress contributes to α-synuclein phosphorylation and up-regulation via polo-like kinase 2 and casein kinase 2
Ranran Wang et al.
NEUROCHEMISTRY INTERNATIONAL (2019)
mGluR2 positive allosteric modulators: an updated patent review (2013-2018)
Andres A. Trabanco et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2019)
Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonism
Imane Frouni et al.
NEUROPHARMACOLOGY (2019)
mGlu receptors in the treatment of Parkinson's disease and L-DOPA-induced dyskinesia
Irene Sebastianutto et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
TRH Analog, Taltirelin Protects Dopaminergic Neurons From Neurotoxicity of MPTP and Rotenone
Cong Zheng et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Parkinson's disease: experimental models and reality
Peizhou Jiang et al.
ACTA NEUROPATHOLOGICA (2018)
The two-century journey of Parkinson disease research
Serge Przedborski
NATURE REVIEWS NEUROSCIENCE (2017)
Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease
Qiu-shuang Zhang et al.
ACTA PHARMACOLOGICA SINICA (2017)
Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization
Filsy Samuel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents
Shuke Nie et al.
NEUROPHARMACOLOGY (2015)
Altered glutamate/GABA equilibrium in aged mice cortex influences cortical plasticity
Monika Liguz-Lecznar et al.
Brain Structure & Function (2015)
Design and Synthesis of Systemically Active Metabotropic Glutamate Subtype-2 and-3 (mGlu2/3) Receptor Positive Allosteric Modulators (PAMs): Pharmacological Characterization and Assessment in a Rat Model of Cocaine Dependence
Raveendra-Panickar Dhanya et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
A further update on the role of excitotoxicity in the pathogenesis of Parkinson's disease
Giulia Ambrosi et al.
JOURNAL OF NEURAL TRANSMISSION (2014)
Levels of the Rab GDP dissociation inhibitor (GDI) are altered in the prenatal restrain stress mouse model of schizophrenia and are differentially regulated by the mGlu2/3 receptor agonists, LY379268 and LY354740
Rosamaria Orlando et al.
NEUROPHARMACOLOGY (2014)
IN VIVO MODULATION OF POLO-LIKE KINASES SUPPORTS A KEY ROLE FOR PLK2 IN SER129 α-SYNUCLEIN PHOSPHORYLATION IN MOUSE BRAIN
M. Bergeron et al.
NEUROSCIENCE (2014)
PLK2 Modulates α-Synuclein Aggregation in Yeast and Mammalian Cells
Elisa Basso et al.
MOLECULAR NEUROBIOLOGY (2013)
mGlu3 receptor and astrocytes: Partners in neuroprotection
Daniela Durand et al.
NEUROPHARMACOLOGY (2013)
Targeting Glutamate Receptors to Tackle the Pathogenesis, Clinical Symptoms and Levodopa-Induced Dyskinesia Associated with Parkinson's Disease
Susan Duty
CNS DRUGS (2012)
Regulation of NMDA receptors by the tyrosine kinase Fyn
Catherine H. Trepanier et al.
FEBS JOURNAL (2012)
Characterization of Kinases Involved in the Phosphorylation of Aggregated α-Synuclein
Elisa A. Waxman et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
Metabotropic glutamate receptors: From the workbench to the bedside
E. Nicoletti et al.
NEUROPHARMACOLOGY (2011)
Activation of group II metabotropic glutamate receptors induces long-term depression of excitatory synaptic transmission in the substantia nigra pars reticulata
Kari A. Johnson et al.
NEUROSCIENCE LETTERS (2011)
MPTP Mouse Models of Parkinson's Disease: An Update
Gloria E. Meredith et al.
JOURNAL OF PARKINSONS DISEASE (2011)
Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease
Colleen M. Niswender et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Involvement of NMDAR2A tyrosine phosphorylation in depression-related behaviour
Sachiko Taniguchi et al.
EMBO JOURNAL (2009)
Impaired glutamate homeostasis and programmed cell death in a chronic MPTP mouse model of Parkinson's disease
G. E. Meredith et al.
EXPERIMENTAL NEUROLOGY (2009)
Polo-like Kinase 2 (PLK2) Phosphorylates α-Synuclein at Serine 129 in Central Nervous System
Kelly J. Inglis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Pharmacological Modulation of Glutamate Transmission in a Rat Model of L-DOPA-Induced Dyskinesia: Effects on Motor Behavior and Striatal Nuclear Signaling
Daniella Rylander et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Cdk5 regulates the phosphorylation of tyrosine 1472 NR2B and the surface expression of NMDA receptors
Shuo Zhang et al.
JOURNAL OF NEUROSCIENCE (2008)
Downregulation of glutamate transporters is associated with elevation in extracellular glutamate concentration following rat microsphere embolism
Feng Han et al.
NEUROSCIENCE LETTERS (2008)
Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder
Eduardo Dunayevich et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Involvement of the Snk-SPAR pathway in glutamate-induced excitotoxicity in cultured hippocampal neurons
Lan-Xiang Wu et al.
BRAIN RESEARCH (2007)
Excitatory synaptic transmission persists independently of the glutamate-glutamine cycle
Kaiwen Kam et al.
JOURNAL OF NEUROSCIENCE (2007)
The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection
Corrado Corti et al.
JOURNAL OF NEUROSCIENCE (2007)
Cellular localization of mGluR3 and mGluR5 mRNAs in normal and injured rat brain
Giuseppa Mudo et al.
BRAIN RESEARCH (2007)
Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease
John P. Anderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Tyrosine phosphorylation of the N-methyl-D-aspartate receptor is enhanced in synaptic membrane fractions of the adult rat hippocampus
SM Goebel et al.
MOLECULAR BRAIN RESEARCH (2005)
Metabotropic glutamate receptors in the basal ganglia motor circuit
PJ Conn et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Enhancement of glutamate uptake mediates the neuroprotection exerted by activating group II or III metabotropic glutamate receptors on astrocytes
HH Yao et al.
JOURNAL OF NEUROCHEMISTRY (2005)
SRC kinases: A hub for NMDA receptor regulation
MW Salter et al.
NATURE REVIEWS NEUROSCIENCE (2004)
Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32
AW Dunah et al.
MOLECULAR PHARMACOLOGY (2004)
LY354740, an mGlu2/3 receptor agonist as a novel approach to treat anxiety/stress
DD Schoepp et al.
STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS (2003)
Protective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice
G Battaglia et al.
NEUROPHARMACOLOGY (2003)
Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear-potentiated startle paradigm in humans
C Grillon et al.
PSYCHOPHARMACOLOGY (2003)
Acute and subchronic MPTP administration differentially affects striatal glutamate synaptic function
S Robinson et al.
EXPERIMENTAL NEUROLOGY (2003)
Differential binding of the AP-2 adaptor complex and PSD-95 to the C-terminus of the NMDA receptor subunit NR2B regulates surface expression
G Lavezzari et al.
NEUROPHARMACOLOGY (2003)
Evaluation of the mGluR2/3 agonist LY379268 in rodent models of Parkinson's disease
TK Murray et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
NMDA receptor regulation by Src kinase signalling in excitatory synaptic transmission and plasticity
DW Ali et al.
CURRENT OPINION IN NEUROBIOLOGY (2001)
Group II metabotropic glutamate receptor activation protects striatal dopaminergic nerve terminals against MPP+-induced neurotoxicity along with brain-derived neurotrophic factor induction
ER Matarredona et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Distribution and roles of metabotropic glutamate receptors in the basal ganglia motor circuit: implications for treatment of Parkinson's Disease and related disorders
ST Rouse et al.
PHARMACOLOGY & THERAPEUTICS (2000)
Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia nigra pars reticulata
SR Bradley et al.
JOURNAL OF NEUROSCIENCE (2000)
分享论文
